Fabrication of mesoporous hydroxycarbonate apatite for oral delivery of poorly water-soluble drug carvedilol

Journal of Non-Crystalline Solids

Volumn 358, Issue 2, 2012, Pages 229-235

  Zhao, Qinfu ^a   Wang, Tianyi ^a   Wang, Jing ^a   Zheng, Li ^a   Jiang, Tongying ^a   Cheng, Gang ^a   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Carvedilol; Drug delivery system; Mesoporous hydroxycarbonate apatite; Poorly soluble drugs

Indexed keywords

AMORPHOUS STATE; BURST RELEASE; CARVEDILOL; CETYLTRIMETHYLAMMONIUM BROMIDE; DISSOLUTION RATES; DRUG CARRIER; DRUG DELIVERY SYSTEM; DRUG DISSOLUTION; DRUG UPTAKE; FOURIER TRANSFORM INFRARED; GASTRIC FLUIDS; HYDROTHERMAL METHODS; HYDROXY CARBONATES; IN-VITRO; INTESTINAL FLUID; MESOPOROUS; MODEL DRUGS; NANO-SIZED; ORAL DELIVERY; PHYSICAL STABILITY; POORLY SOLUBLE DRUGS; POORLY WATER-SOLUBLE DRUGS; POWDER X RAY DIFFRACTION; RELEASE PROPERTY; STABILITY TESTS; STRUCTURE AND MORPHOLOGY; UV-VIS SPECTROPHOTOMETRY;

ADSORPTION; AMMONIUM COMPOUNDS; APATITE; BIOCHEMISTRY; BROMINE COMPOUNDS; CALCIUM CARBONATE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DELIVERY; MICROCRYSTALS; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; SURFACE ACTIVE AGENTS; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

MESOPOROUS MATERIALS;

EID: 81855194017     PISSN: 00223093     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnoncrysol.2011.09.020     Document Type: Article

References (32)

1. F. Kesisoglou, S. Panmai, and Y. Wu Nanosizing- oral formulation development and biopharmaceutical evaluation Adv. Drug Deliv. Rev. 59 2007 631 644 (Pubitemid 47285408)
2. K. Sachs-Barrable, S.D. Lee, E.K. Wasa, S.J. Thornton, and K.M. Wasan Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections Adv. Drug Deliv. Rev. 60 2008 692 701
3. C. Wu, Z.Y. Wang, Z.Z. Zhi, T.Y. Jiang, and J.H. Zhang Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs Int. J. Pharm. 403 2011 162 169
4. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting Adv. Drug Deliv. Rev. 46 2001 3 26 (Pubitemid 33653411)
5. C.A. Lipinski Poor aqueous solubility - an industry wide problem in drug discovery Am. Pharm. Rev. 53 2002 82 85
6. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60 (Pubitemid 30326688)
7. T. Vasconcelos, B. Sarmento, and P. Costa Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov. Today 12 2007 1068 1075 (Pubitemid 350186132)
8. S.M. Badr-Eldin, S.A. Elkheshen, and M.M. Ghorab Inclusion complexes of tadalafil with natural and chemically modified b-cyclodextrins I: preparation and in vitro evaluation Eur. J. Pharm. Biopharm. 70 2008 819 827
9. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
10. C.M. Keck, and R.H. Muüller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
11. A.R. Mohammed, N. Weston, A.G.A. Coombes, M. Fitzgerald, and Y. Perrie Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability Int. J. Pharm. 285 2004 23 34 (Pubitemid 39361533)
12. Y. Mizushima, T. Ikoma, J. Tanaka, K. Hoshi, and T. Ishihara Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs J. Control. Release 110 2005 260 265 (Pubitemid 41829564)
13. W. Xia, and J. Chang Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system J. Control. Release 110 2006 522
14. F. Ye, H.F. Guo, H.J. Zhang, and X.L. He Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system Acta Biomater. 6 2010 2212 2218
15. C.M. Zhang, C.X. Li, S.S. Huang, Z.Y. Hou, Z.Y. Cheng, P.P. Yang, C. Peng, and J. Lin Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery Biomaterials 31 2010 3374 3383
16. D.M. Dabbs, and I.A. Aksay Self-assembled ceramics produced by complex-fluid templation Annu. Rev. Phys. Chem. 51 2000 601 622
17. S.V. Dorozhkin, and M. Epple Biological and medical significance of calcium phosphates Angew. Chem. Int. Ed. 41 2002 3130
18. V.B. Pokharkar, L.P. Mandpe, M.N. Padamwar, A.A. Ambike, K.R. Mahadik, and A. Paradkar Development, characterization and stabilization of amorphous form of a low Tg drug Powder Technol. 167 2006 20 25 (Pubitemid 44215984)
19. Y.P. Guo, Y. Zhou, D.C. Jia, and H.X. Tang Fabrication and characterization of hydroxycarbonate apatite with mesoporous structure Micropor. Mesopor. Mat. 118 2009 480 488
20. 3 nanospheres and their transformation to hollow hydroxyapatite nanospheres J. Colloid Interface Sci. 352 2010 393 400
21. Y.Z. Zhang, T.Y. Jiang, Q. Zhang, and S.L. Wang Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property Eur. J. Pharm. Biopharm. 76 2010 17 23
22. L. Cao, T. Man, and M. Kruk Synthesis of ultra-large-pore SBA-15 silica with two-dimensional hexagonal structure using triisopropylbenzene as micelle expander Chem. Mater. 21 2009 1144 1153
23. P. Schmidt-Winkel, W.W. Lukens Jr., D. Zhao, P. Yang, B.F. Chmelka, and G.D. Stucky Mesocellular siliceous foams with uniformly sized cells and windows J. Am. Chem. Soc. 121 1999 254 255 (Pubitemid 29047147)
24. X.A. Zhang, W.J. Wu, J.F. Wang, and X.Z. Tian Direct synthesis and characterization of highly ordered functional mesoporous silica thin films with high amino-groups content Appl. Surf. Sci. 254 2008 2893 2899
25. Q.J. He, X.Z. Cui, F.M. Cui, L.M. Guo, and J.L. Shi Size-controlled synthesis of monodispersed mesoporous silica nano-spheres under a neutral condition Micropor. Mesopor. Mat. 117 2009 609 616
26. Z.G. Teng, Y.D. Han, J. Li, F. Yan, and W.S. Yang Preparation of hollow mesoporous silica spheres by a sol-gel/emulsion approach Micropor. Mesopor. Mat. 127 2010 67 72
27. J. Salonen, L. Laitinen, A.M. Kaukonen, J. Tuura, and M. Björkqvist Mesoporous silicon microparticles for oral drug delivery: loading and release five model drugs J. Control. Release 108 2005 362 374 (Pubitemid 41608668)
28. C.M. Li, G.D. Botsaris, and D.L. Kaplan Selective in vitro effect of peptides on calcium carbonate crystallization Cryst. Growth Des. 2 2002 387
29. E.C. Moreno, M. Kresak, and R.T. Zahradni Fluoridated hydroxyapatite solubility and caries formation Nature 247 1974 64
30. K.J. Westin, and A.C. Rasmuson Nucleation of calcium carbonate in presence of citric acid, DTPA, EDTA and pyromellitic acid J. Colloid Interface Sci. 282 2005 370
31. Y.C. Hu, J. Wang, Z.Z. Zhi, T.Y. Jiang, and S.L. Wang Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug J. Colloid Interf. Sci. 363 2011 410 417
32. B.C. Hancock, and M. Parks What is the true solubility advantage for amorphous harmaceuticals? Pharm. Res. 17 2000 397 404 (Pubitemid 30395293)